From October 1, 2022 to December 31, 2022, the company has repurchased 4,422,140 shares, representing 0.61% for CNY 27.49 million. With this, the company has completed the repurchase of 8,301,493 shares, representing 1.15% for CNY 56.25 million under the buyback announced on March 10, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.71 CNY | -0.42% | -4.27% | -14.83% |
1st Jan change | Capi. | |
---|---|---|
-14.83% | 457M | |
+20.29% | 43.46B | |
+25.52% | 22.61B | |
+16.89% | 15.15B | |
+23.47% | 14.83B | |
+57.84% | 13.08B | |
-0.05% | 6.79B | |
-12.22% | 6.72B | |
-8.87% | 5.73B | |
+12.71% | 5.45B |
- Stock Market
- Equities
- 603669 Stock
- News Lionco Pharmaceutical Group Co.,Ltd.
- Tranche Update on Lionco Pharmaceutical Group Co.,Ltd.'s Equity Buyback Plan announced on March 10, 2022.